Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasis

BACKGROUND: Evidence of the comparative effectiveness of biological therapies for psoriasis on health‐related quality of life (HRQoL) in routine clinical practice is limited. OBJECTIVES: To examine the comparative effectiveness of adalimumab, etanercept and ustekinumab on HRQoL in patients with psor...

Descripción completa

Detalles Bibliográficos
Autores principales: Iskandar, I.Y.K., Ashcroft, D.M., Warren, R.B., Lunt, M., McElhone, K., Smith, C.H., Reynolds, N.J., Griffiths, C.E.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487951/
https://www.ncbi.nlm.nih.gov/pubmed/28369707
http://dx.doi.org/10.1111/bjd.15531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487951/
https://www.ncbi.nlm.nih.gov/pubmed/28369707
http://dx.doi.org/10.1111/bjd.15531

Ejemplares similares